Anderson, RonaldRapoport, Bernardo LeonSteel, Helen CarolynTheron, Annette J.2024-05-222024-05-222023-07Anderson, R.; Rapoport, B.L.; Steel, H.C.; Theron, A.J. Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer. International Journal of Molecular Sciences 2023, 24, 11927. https://doi.org/10.3390/ijms241511927.1661-6596 (print)1422-0067 (online)10.3390/ijms241511927http://hdl.handle.net/2263/96177Aside from their key protective roles in hemostasis and innate immunity, platelets are now recognized as having multifaceted, adverse roles in the pathogenesis, progression and outcome of many types of human malignancy. The most consistent and compelling evidence in this context has been derived from the notable association of elevated circulating platelet counts with the onset and prognosis of various human malignancies, particularly lung cancer, which represents the primary focus of the current review. Key topics include an overview of the association of lung cancer with the circulating platelet count, as well as the mechanisms of platelet-mediated, pro-tumorigenic immunosuppression, particularly the role of transforming growth factor beta 1. These issues are followed by a discussion regarding the pro-tumorigenic role of platelet-derived microparticles (PMPs), the most abundant type of microparticles (MPs) in human blood. In this context, the presence of increased levels of PMPs in the blood of lung cancer patients has been associated with tumor growth, invasion, angiogenesis and metastasis, which correlate with disease progression and decreased survival times. The final section of the review addresses, firstly, the role of cancer-related platelet activation and thrombosis in the pathogenesis of secondary cardiovascular disorders and the associated mortality, particularly in lung cancer, which is second only to disease progression; secondly, the review addresses the potential role of antiplatelet agents in the adjunctive therapy of cancer.en© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.ImmunosuppressionLung cancerLung-cancer-associated thrombosisPlateletsPlatelet factor 4Transforming growth factor beta 1Tissue factorPlatelet-derived microparticles (PMPs)Platelet-derived vesiclesSDG-03: Good health and well-beingArticle